litlas
ログインアカウント作成

Partow Kebriaei

1995–2026 年に発表

184
論文数
21,832
被引用数
79
h 指数
165
i10 指数

被引用数

Partow Kebriaei の年別被引用数1990 年: 被引用 1 件1991 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 20 件1997 年: 被引用 35 件1998 年: 被引用 34 件1999 年: 被引用 32 件2000 年: 被引用 18 件2001 年: 被引用 16 件2002 年: 被引用 12 件2003 年: 被引用 19 件2004 年: 被引用 11 件2005 年: 被引用 10 件2006 年: 被引用 9 件2007 年: 被引用 12 件2008 年: 被引用 5 件2009 年: 被引用 24 件2010 年: 被引用 41 件2011 年: 被引用 55 件2012 年: 被引用 64 件2013 年: 被引用 147 件2014 年: 被引用 119 件2015 年: 被引用 165 件2016 年: 被引用 146 件2017 年: 被引用 175 件2018 年: 被引用 224 件2019 年: 被引用 756 件2020 年: 被引用 1,072 件2021 年: 被引用 1,192 件2022 年: 被引用 968 件2023 年: 被引用 809 件2024 年: 被引用 1,511 件2025 年: 被引用 797 件2026 年: 被引用 18 件1992〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,116 件、この内訳の 30.7%中国: 引用元論文 1,118 件、この内訳の 11%ドイツ: 引用元論文 733 件、この内訳の 7.2%イタリア: 引用元論文 504 件、この内訳の 5%イギリス: 引用元論文 492 件、この内訳の 4.8%フランス: 引用元論文 468 件、この内訳の 4.6%スペイン: 引用元論文 353 件、この内訳の 3.5%オランダ: 引用元論文 260 件、この内訳の 2.6%カナダ: 引用元論文 257 件、この内訳の 2.5%スイス: 引用元論文 219 件、この内訳の 2.1%オーストラリア: 引用元論文 214 件、この内訳の 2.1%日本: 引用元論文 201 件、この内訳の 2%
0%30.7%その他 21.9%

機関

分野

  • Medicine77.4%
  • Biochemistry, Genetics and Molecular Biology11%
  • Immunology and Microbiology9.9%
  • Engineering0.7%
  • Neuroscience0.4%
  • Pharmacology, Toxicology and Pharmaceutics0.1%
  • その他0.5%

トピック

  • CAR-T cell therapy research18.3%
  • Immune Cell Function and Interaction7.7%
  • Hematopoietic Stem Cell Transplantation5.2%
  • Virus-based gene therapy research4.8%
  • Acute Lymphoblastic Leukemia research4.4%
  • Acute Myeloid Leukemia Research3.3%
  • その他56.3%

共著者

全論文

検索で開く
  1. Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

    著者: Enli Liu, David Marín, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson, Rafet Başar, Lucila Nassif Kerbauy, Bethany Overman, Peter F. Thall, Mecit Kaplan, Vandana Nandivada, Indresh Kaur, Ana Karen Nunez Cortes, Kai Cao, May Daher, Chitra Hosing, Evan N. Cohen, Partow Kebriaei, Rohtesh S. Mehta, Sattva S. Neelapu, Yago Nieto, Michael Wang, William G. Wierda, Michael J. Keating, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani - New England Journal of Medicine 2020 被引用: 2,139

  2. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

    著者: Sattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, William G. Wierda, Cristina Gutiérrez, Frederick L. Locke, Krishna V. Komanduri, Yi Lin, Nitin Jain, Naval Daver, Jason R. Westin, Alison Gulbis, Monica Loghin, John de Groot, Sherry Adkins, Suzanne E. Davis, Katayoun Rezvani, Patrick Hwu, Elizabeth J. Shpall - Nature Reviews Clinical Oncology 2017 被引用: 2,380

  3. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

    著者: David Marín, Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou, Vakul Mohanty, Merve Dede, Yago Nieto, Nadima Uprety, Sunil Acharya, Enli Liu, Jeffrey M. Wilson, Pinaki P. Banerjee, Homer A. Macapinlac, Christina Ganesh, Peter F. Thall, Roland L. Bassett, Mariam Ammari, Sheetal Rao, Kai Cao, Mayra Shanley, Mecit Kaplan, Chitra Hosing, Partow Kebriaei, Loretta J. Nastoupil, Christopher R. Flowers, Sadie Mae Moseley, Paul Lin, Sonny Ang, Uday Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Ken Chen, Elizabeth J. Shpall, Katayoun Rezvani - Nature Medicine 2024 被引用: 457

  4. Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells

    著者: Lenka V. Hurton, Harjeet Singh, Amer Najjar, Kirsten C. Switzer, Tiejuan Mi, Sourindra N. Maiti, Simon Olivares, Brian Rabinovich, Helen Huls, Marie-Andrée Forget, Vrushali Datar, Partow Kebriaei, Dean A. Lee, Richard E. Champlin, Laurence J.N. Cooper - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 被引用: 458

  5. Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

    著者: David S. Hong, Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski, Jeffrey Clarke, Dejka M. Araujo, George R. Blumenschein, Partow Kebriaei, Quan Lin, Alex J. Tipping, Joseph P. Sanderson, Ruoxi Wang, Trupti Trivedi, Thejo Annareddy, Jane P. F. Bai, Stavros Rafail, Amy Sun, Lilliam Fernandes, Jean‐Marc Navenot, Frederic D. Bushman, J.K. Everett, Derin F. Karadeniz, Robyn Broad, Martin Isabelle, Revashnee Naidoo, Natalie Bath, Gareth Betts, Zohar Wolchinsky, Dzmitry G. Batrakou, Erin Van Winkle, Erica Elefant, Armin Ghobadi, Amanda F. Cashen, Anne Grand’Maison, Philip L. McCarthy, Paula M. Fracasso, Elliot Norry, Dennis Williams, Mihaela Druta, David A. Liebner, Kunle Odunsi, Marcus O. Butler - Nature Medicine 2023 被引用: 194

  6. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

    著者: Hiroki Torikai, Andreas Reik, Pei-Qi Liu, Yuanyue Zhou, Ling Zhang, Sourindra N. Maiti, Helen Huls, Jeffrey C. Miller, Partow Kebriaei, Brian Rabinovitch, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Luigi Naldini, Edward J. Rebar, Philip D. Gregory, Michael C. Holmes, Laurence J.N. Cooper - Blood 2012 被引用: 521

  7. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

    著者: Reuben Benjamin, Nitin Jain, Marcela V. Maus, Nicolas Boissel, Charlotte Graham, Agnieszka Jóźwik, Deborah Yallop, Marina Konopleva, Matthew J. Frigault, Takanori Teshima, Koji Kato, Floriane Boucaud, Svetlana Balandraud, Athos Gianella-Borradori, Florence Binlich, Ibtissam Marchiq, Sandra Dupouy, Maria Almena-Carrasco, Matthieu Pannaux, Sylvain Fouliard, Éolia Brissot, Mohamad Mohty, Reuben Benjamin, Charlotte Graham, Agnieszka Jóźwik, Deborah Yallop, Laarni Bonganay, Lorraine Catt, Jackie Chappell, Gary Cheung, Vicky Chu, Kirsty Cuthill, Steven Devereux, Alan Dunlop, Rose Ellard, Farzin Farzeneh, Najeem Folarin, Elka Giemza, Shireen Kassam, Majid Kazmi, Andrea Kühnl, Jen Lewis, M.Yu. Liskova, Alice Mason, Victoria Metaxa, Ghulam Mufti, Helena Munro, Antonio Pagliuca, Piers Patten, Victoria Potter, Carmel Rice, Adeel Saleem, Robin Sanderson, Orla Stewart, Elias Jabbour, Nitin Jain, Emily Jones, Hagop M. Kantarjian, Partow Kebriaei, Marina Konopleva, Kara McGee, William G. Wierda, Jami Brown, Keagan S. Casey, Matthew J. Frigault, Hanno Hock, Richard Mathews, Marcela V. Maus, Meaghan A McKeown, Thomas R. Spitzer, Vesselina Toncheva, Élie Azoulay, Nicolas Boissel, Sophie Caillat‐Zucman, Karine Celli‐Lebras, Emmanuelle Clappier, Raphaël Itzykson, Jérôme Larghero, Étienne Lengliné, Isabelle Madelaine, Martine Meunier, Florence Rabian, Emmanuel Raffoux, Marie-Thérèse Tremorin, Agnès Bonnin, Éolia Brissot, Anne Daguenel-Nguyen, Rémy Duléry, Tounes Ledraa, Florent Malard, Clémence Mediavilla, Mohamad Mohty, Anne Vekhoff, Takanori Teshima, Koji Kato - The Lancet Haematology 2022 被引用: 136

  8. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant

    著者: Laura W. Dillon, Gege Gui, Kristin Page, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee, Scott L. Zeger, Firas El Chaer, Stephen R. Spellman, Alan Howard, Karen Chen, Jeffery J. Auletta, Steven M. Devine, Antonio Jiménez, Marcos J.G. De Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Daniel J. Weisdorf, Christopher S. Hourigan - JAMA 2023 被引用: 144

  9. Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

    著者: Paolo Strati, Sairah Ahmed, Fateeha Furqan, Luis Fayad, Hun Ju Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphaël Steiner, Michael Wang, Chelsea C. Pinnix, Sandra B. Horowitz, Lei Feng, Ryan Sun, Catherine M. Claussen, Misha Hawkins, Nicole Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J. Shpall, Michael R. Green, Christopher R. Flowers, Jason R. Westin, Sattva S. Neelapu - Blood 2021 被引用: 214

  10. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

    著者: Partow Kebriaei, Harjeet Singh, M. Helen Huls, Matthew J. Figliola, Roland L. Bassett, Simon Olivares, Bipulendu Jena, Margaret J. Dawson, Pappanaicken R. Kumaresan, Shihuang Su, Sourindra N. Maiti, Jianliang Dai, Branden S. Moriarity, Marie-Andrée Forget, Vladimir Senyukov, Aaron Orozco, Tingting Liu, Jessica M McCarty, Rineka N. Jackson, Judy S. Moyes, Gabriela Rondón, Muzaffar H. Qazilbash, Stefan O. Ciurea, Amin M. Alousi, Yago Nieto, Katy Rezvani, David Marín, Uday Popat, Chitra Hosing, Elizabeth J. Shpall, Hagop M. Kantarjian, Michael J. Keating, William G. Wierda, Kim‐Anh Do, David A. Largaespada, Dean A. Lee, Perry B. Hackett, Richard E. Champlin, Laurence J.N. Cooper - Journal of Clinical Investigation 2016 被引用: 504

  11. Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

    著者: Paolo Strati, Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson, Sandra B. Horowitz, Anne Rain Brown, Bryan Do, Maria Alma Rodriguez, Ranjit Nair, Elizabeth J. Shpall, Michael R. Green, Sattva S. Neelapu, Jason R. Westin - Blood Advances 2020 被引用: 197

  12. CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

    著者: Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Rodríguez‐Torres, Gabriela Rondón, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason R. Westin, Luis Fayad, Hun Ju Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphaël Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy Ramdial, Fevzi Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed - Blood Advances 2021 被引用: 146

  13. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse

    著者: Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Marina Konopleva, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Walid Macaron, Tapan M. Kadia, Sa A. Wang, Jeffrey L. Jorgensen, Joseph D. Khoury, Musa Yılmaz, Partow Kebriaei, Koichi Takahashi, Guillermo Garcia‐Manero, Naval Daver, Sean M. Post, Xuelin Huang, Steven M. Kornblau, S. Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Elias Jabbour - Blood Advances 2022 被引用: 112

  14. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

    著者: Paolo Strati, Ankur Varma, Sherry Adkins, Loretta J. Nastoupil, Jason R. Westin, Fredrick B. Hagemeister, Nathan Fowler, Hun Ju Lee, Luis Fayad, Felipe Samaniego, Sairah Ahmed, Yiming Chen, Sandra Horowitz, Sara Arafat, Swapna Johncy, Partow Kebriaei, Victor E. Mulanovich, Ella Ariza‐Heredia, Sattva S. Neelapu - Haematologica 2020 被引用: 149

  15. Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1

    著者: Nicholas J. Short, Elias Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Sanam Loghavi, Fadi Haddad, Musa Yılmaz, Ghayas C. Issa, Partow Kebriaei, Steven M. Kornblau, Sarah Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Hagop M. Kantarjian - American Journal of Hematology 2023 被引用: 73

  16. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    著者: Ann M. Leen, Catherine M. Bollard, Adam Mendizabal, Elizabeth J. Shpall, Paul Szabolcs, Joseph H. Antin, Neena Kapoor, Sung‐Yun Pai, Scott D. Rowley, Partow Kebriaei, Bimalangshu R. Dey, Bambi Grilley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop - Blood 2013 被引用: 548

  17. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

    著者: Hiroki Torikai, Andreas Reik, Frank Soldner, Edus H. Warren, Carrie Yuen, Yuanyue Zhou, Denise L. Crossland, Helen Huls, Nicholas Littman, Ziying Zhang, Scott S. Tykodi, Partow Kebriaei, Dean A. Lee, Jeffrey C. Miller, Edward J. Rebar, Michael C. Holmes, Rudolf Jaenisch, Richard E. Champlin, Philip D. Gregory, Laurence J.N. Cooper - Blood 2013 被引用: 305

  18. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

    著者: Partow Kebriaei, Jack Hayes, Andrew Daly, Joseph P. Uberti, David I. Marks, Robert J. Soiffer, Edmund K. Waller, Elizabeth Burke, Donna Skerrett, Elizabeth J. Shpall, Paul J. Martin - Biology of Blood and Marrow Transplantation 2019 被引用: 201

  19. Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results

    著者: Hagop M. Kantarjian, Nicholas J. Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fadi Haddad, Issa F. Khouri, Courtney D. DiNardo, Naveen Pemmaraju, William G. Wierda, Guillermo Garcia‐Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey L. Jorgensen, Monica Kwari, Susan O’Brien, Farhad Ravandi, Elias Jabbour - American Journal of Hematology 2023 被引用: 98

  20. Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

    著者: Hagop M. Kantarjian, Daniel J. DeAngelo, Anjali S. Advani, Matthias Stelljes, Partow Kebriaei, Ryan D. Cassaday, Akil Merchant, Naohito Fujishima, Toshiki Uchida, María Calbacho, Anna Ejduk, Susan O’Brien, Elias Jabbour, Hui Zhang, Barbara Sleight, Erik Vandendries, David I. Marks - The Lancet Haematology 2017 被引用: 212

  21. Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia

    著者: Hagop M. Kantarjian, Fadi Haddad, Nitin Jain, Koji Sasaki, Nicholas J. Short, Sanam Loghavi, Rashmi Kanagal‐Shamanna, Jeffrey L. Jorgensen, Issa F. Khouri, Partow Kebriaei, Yesid Alvarado, Tapan M. Kadia, Shilpa Paul, Guillermo Garcia‐Manero, Bouthaina S. Dabaja, Musa Yılmaz, Jovitta Jacob, Rebecca Garris, Susan O’Brien, Farhad Ravandi, Elias Jabbour - Journal of Hematology & Oncology 2023 被引用: 47

  22. Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

    著者: Paolo Strati, Loretta J. Nastoupil, Jason R. Westin, Luis Fayad, Sairah Ahmed, Nathan Fowler, Fredrick B. Hagemeister, Hun Ju Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphaël Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles Martinez, Misha Hawkins, Nicole Johnson, Prachee Singh, Haleigh Mistry, Sandra Horowitz, Shirley St. George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, Tom Chi - Blood Advances 2020 被引用: 114

  23. US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

    著者: Farhad Ravandi, Megan Othus, Susan O’Brien, Stephen J. Forman, Chul S. Ha, Jeffrey Y.C. Wong, Martin S. Tallman, Elisabeth Paietta, Janis Racevskis, Geoffrey L. Uy, Mary M. Horowitz, Naoko Takebe, Richard F. Little, Uma Borate, Partow Kebriaei, Laura Kingsbury, Hagop M. Kantarjian, Jerald P. Radich, Harry P. Erba, Frederick R. Appelbaum - Blood Advances 2016 被引用: 193

  24. Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia

    著者: Guillaume Richard‐Carpentier, Elias Jabbour, Nicholas J. Short, Caitlin R. Rausch, J. Michael Savoy, Prithviraj Bose, Musa Yılmaz, Nitin Jain, Gautam Borthakur, Maro Ohanian, Yesid Alvarado, Michael Rytting, Partow Kebriaei, Marina Konopleva, Hagop M. Kantarjian, Farhad Ravandi - Clinical Lymphoma Myeloma & Leukemia 2019 被引用: 127